Quality Assurance of Metabolomics

Mounir Bouhifd 1, Richard Beger 2, Thomas Flynn 3, Lining Guo 4, Georgina Harris 1, Helena Hogberg 1, Rima Kaddurah-Daouk 5, Hennicke Kamp 6, Andre Kleensang 1, Alexandra Maertens 1, Shelly Odwin-DaCosta 1, David Pamies 1, Donald Robertson 7, Lena Smirnova 1, Jinchun Sun 2, Liang Zhao 1 and Thomas Hartung 1, 8 1Johns Hopkins University, Bloomberg School of Public Health, Center for Alternatives to Animal Testing, Baltimore, MD, USA; 2US Food and Drug Administration, National Center for Toxicological Research, Division of Systems Biology, Jefferson, AR, USA; 3US Food and Drug Administration, Center for Food Safety and Applied Nutrition, Laurel, MD, USA; 4Metabolon, Inc., Durham, NC, USA; 5Department of Psychiatry and Behavioral Sciences, Duke Institute for Brain Sciences, Duke University, Durham, NC, USA; 6Experimental Toxicology and Ecology, BASF SE, Ludwigshafen am Rhein, Germany; 7Bristol-Myers Squibb Pharmaceutical Co., Princeton, NJ, USA; 8CAAT-Europe, University of Konstanz, Germany